One of the experimentally verified 3′RTK fusions (ATP2B1-ERBB2) from breast cancer sample BC-105 has not been previously included in any of the three most comprehensive fusion databases (ChimerDB, ChiTaRS, and TumorFusions). Here, ATP2B1 is linked to breast carcinoma.